Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zanotti

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2002
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphomaR Zanotti, A Trolese, A Ambrosetti, et al.
British Journal of Haematology|August 1, 1990
Increased serum levels of soluble IL-2 receptor, CD30 and CD8 molecules, and gamma-interferon in angioimmunoblastic lymphadenopathy: possible pathogenetic role of immunoactivation mechanismsG Pizzolo, H Stein, O Josimovic-Alasevic, et al.
International Journal of Clinical & Laboratory Research|January 1, 1995
Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disordersF Vinante, A Vassanelli, R Zanotti, et al.
American Journal of Clinical Pathology|August 1, 1989
Increased levels of soluble interleukin-2 receptor in non-Hodgkin's lymphomas. Relationship with clinical, histologic, and phenotypic featuresM Chilosi, G Semenzato, F Vinante, et al.
International Urology and Nephrology|February 5, 2024
Male sling adjustability: does it truly matter?Rafael R Zanotti, Fernando Lustosa, Andre C Matos, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1989
Serum levels of soluble CD8 are increased in patients with B chronic lymphocytic leukemiaG Semenzato, F Siviero, F Vinante, et al.
Clinical Immunology and Immunopathology|January 1, 1989
Increased levels of soluble CD8 molecule in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related disordersC Agostini, G Semenzato, F Vinante, et al.
British Journal of Haematology|October 1, 1989
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulkA Ambrosetti, G Semenzato, M Prior, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Eighty-one percent event-free survival in advanced Burkitt's lymphoma/leukemia: no differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocolG Todeschini, C Tecchio, D Degani, et al.
Cancer|August 1, 1989
Functional analysis of cytotoxic cells in patients with acute nonlymphoblastic leukemia in complete remissionL Trentin, G Pizzolo, C Feruglio, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2002
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphomaR Zanotti, A Trolese, A Ambrosetti, et al.
British Journal of Haematology|August 1, 1990
Increased serum levels of soluble IL-2 receptor, CD30 and CD8 molecules, and gamma-interferon in angioimmunoblastic lymphadenopathy: possible pathogenetic role of immunoactivation mechanismsG Pizzolo, H Stein, O Josimovic-Alasevic, et al.
International Journal of Clinical & Laboratory Research|January 1, 1995
Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disordersF Vinante, A Vassanelli, R Zanotti, et al.
American Journal of Clinical Pathology|August 1, 1989
Increased levels of soluble interleukin-2 receptor in non-Hodgkin's lymphomas. Relationship with clinical, histologic, and phenotypic featuresM Chilosi, G Semenzato, F Vinante, et al.
International Urology and Nephrology|February 5, 2024
Male sling adjustability: does it truly matter?Rafael R Zanotti, Fernando Lustosa, Andre C Matos, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1989
Serum levels of soluble CD8 are increased in patients with B chronic lymphocytic leukemiaG Semenzato, F Siviero, F Vinante, et al.
Clinical Immunology and Immunopathology|January 1, 1989
Increased levels of soluble CD8 molecule in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related disordersC Agostini, G Semenzato, F Vinante, et al.
British Journal of Haematology|October 1, 1989
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulkA Ambrosetti, G Semenzato, M Prior, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Eighty-one percent event-free survival in advanced Burkitt's lymphoma/leukemia: no differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocolG Todeschini, C Tecchio, D Degani, et al.
Cancer|August 1, 1989
Functional analysis of cytotoxic cells in patients with acute nonlymphoblastic leukemia in complete remissionL Trentin, G Pizzolo, C Feruglio, et al.
Pageof 5